Skip to content

Vericel VCEL Net debt / EBITDA

Net debt / EBITDA at other companies

Stryker logo
StrykerSYK
1.9×-1.3×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
3.1×+0.6×
LeMaitre Vascular logo
LeMaitre VascularLMAT
-0.1×0.0×
Globus Medical logo
Globus MedicalGMED
-0.5×-0.1×
Johnson & Johnson logo
Johnson & JohnsonJNJ
+0.5×

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

Based on the most recent quarter.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's net debt / EBITDA?
Vericel (VCEL) reported net debt / EBITDA of -0.5× in Q1 2026.
How has Vericel's net debt / EBITDA changed year-over-year?
Vericel's net debt / EBITDA decreased by 110.3% year-over-year, from 5× to -0.5×.
What is the long-term trend for Vericel's net debt / EBITDA?
Over 2 years (2020 to 2025), Vericel's net debt / EBITDA has grown at a -81.8% compound annual growth rate (CAGR), from 4.1× to -0.1×.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.